IDO1 and major depressive disorder: The current study sought to explore whether CAVO ameliorated depression-like behaviors by inhibiting microglia activation, regulating release of inflammatory factors, downregulating expression of IDO, and increasing 5-HT synthesis in PFC of CUMS rats.